Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis

Nonalcoholic fatty liver disease is becoming the most common chronic liver disease in Western countries, and limited therapeutic options are available. Here we uncovered a role for intestinal hypoxia-inducible factor (HIF) in hepatic steatosis. Human-intestine biopsies from individuals with or witho...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nat Med
Egile Nagusiak: Xie, Cen, Yagai, Tomoki, Luo, Yuhong, Liang, Xianyi, Chen, Tao, Wang, Qiong, Sun, Dongxue, Zhao, Jie, Ramakrishnan, Sadeesh K, Sun, Lulu, Jiang, Chunmei, Xue, Xiang, Tian, Yuan, Krausz, Kristopher W, Patterson, Andrew D, Shah, Yatrik M, Wu, Yue, Jiang, Changtao, Gonzalez, Frank J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410352/
https://ncbi.nlm.nih.gov/pubmed/29035368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4412
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak